Market News
Market news
-
News Hyphenated technique reveals valuable information about plasma proteins
Researchers show how an AF4-ICP-MS system is able to obtain valuable information on the multi-element speciation and absolute molecular mass of human plasma proteins such as Albumin and Transferrin. -
News Turkish pharma grows by 15.6%, as CPHI Istanbul shares MENA trends and challenges for 2016
Next 5 years will see more outsourcing, vaccine, biotech development and harmonisation in MENA region. -
News Brexit would irreparably damage UK pharma industry
A Brexit in the upcoming EU referendum could directly damage the UK pharmaceutical industry, according to NonStop Recruitment. -
News New Sartorius Stedim BioOutsource microsite goes live
Cellca’s cell line and upstream process development services now integrated. -
News ASCO 2016: Roche’s latest Tecentriq results underline potential to dominate bladder cancer market
The launch of Roche’s recently-approved PD-1 immune checkpoint inhibitor Tecentriq will usher in a dramatic change in the treatment paradigm of metastatic bladder cancer, says GlbalData. -
News Pharmaceutical companies increasingly looking to innovate high-risk, first-in-class products
'Imperatives for pharmaceutical companies include reducing product development costs, maximizing the annual product revenue, and optimizing the life cycle of a drug,' says GBI Research. -
News Sartorius Stedim Biotech presents Virosart Media
Offers a fast and cost-effective solution for manufacturers to reduce the risk of virus contamination resulting from raw materials during fermentation. -
News Deacom's AutoFinisher automates serialized and catch weight production
New AutoFinisher moves manufacturing jobs from scale to label in under one second. -
News Dr Reddy’s to acquire product portfolio from Teva for US Market
The portfolio being acquired is a mix of filed ANDAs pending approval and an approved ANDA. -
News Merck to acquire Afferent Pharmaceuticals
Afferent Pharmaceuticals is a leader in the development of therapeutic candidates targeting the P2X3 receptor for the treatment of common, poorly-managed, neurogenic conditions. -
News Integrated DNA Technologies acquires oligonucleotide synthesis company ValueGene
Company welcomes new customers with promise to provide seamless support for genomics research. -
News Lonza and bluebird bio establish a long-term commercial manufacturing agreement for Lenti-D and LentiGlobin drug products
Agreement provides bluebird bio with a path to commercial supply including dedicated production suites within Lonza’s state-of-the-art facility, which is currently under construction. -
News AstraZeneca enters commercialisation agreement with Aspen for anaesthetic medicines portfolio
Agreement expands commercial reach for anaesthetics and supports the Company’s sharp focus on innovative new medicines in its three main therapy areas. -
News Merck expands its Investment Fund Merck Ventures
Total fund size doubled to up to €300 million. -
News Alvotech opens state-of-the-art biosimilar facility in Iceland
The new facility will significantly increase Alvotech’s production capacity enabling the group to produce higher yields at lower costs. -
News Disruptive technologies and emerging trends drive life science transformation
New business models and behavioural shifts create opportunities for growth. -
News Sun Pharma divests US manufacturing units
Divest two oral solid dosage manufacturing facilities to Frontida BioPharm. -
News Cobra Biologics and Touchlight collaborate on production of next generation DNA constructs
The collaboration will optimise the manufacture of AAV vectors to support gene therapy and regenerative medicine. -
News Meningococcal vaccines market set to approach $1.8 billion by 2025
The provision of a single vaccine that can protect the population against all prevalent serogroups is the most important opportunity for companies hoping to access a large market share, says GlobalData. -
News Merck explores new risks for biopharma with the EIU
New approaches for mitigating risk associated with new growth strategies. -
News NovaBiotics highlights importance of a co-ordinated approach to antimicrobial resistance
New multi-action, multi-strain anti-infectives needed to win battle against AMR. -
News Catalent opens new clinical supply facility in its Japan campus with studies starting this month
The site will serve the needs of both domestic and global clinical trial sponsors. -
News SGS introduces new hydrogen deuterium exchange capabilities for protein characterisation and biopharmaceutical development
Company will be one of the first service providers to offer HDX-MS in a cGMP environment. -
News Fujifilm Diosynth collaborates with MSD on a new 20,000-L microbial biologics facility
Enables Fujifilm Diosynth’s customers to benefit from MSD’s strong track record with large-scale microbial operations. -
News Hovione opens a new sales and customer support office in Japan
Japan is a strategic market for Hovione where the company is growing both its off-patent APIs and its contract manufacturing businesses. -
News Experts analyse growth in the finished dosage market ahead of CPHI Worldwide launch
New drug delivery and bioavailability technology driving growth globally. -
News Mylan launches generic Cleocin solution
Product is indicated for the treatment of serious infections caused by susceptible anaerobic bacteria and susceptible strains of streptococci, pneumococci and staphylococci. -
News Shire completes combination with Baxalta
Combined company expected to deliver double-digit compound annual top-line growth with over $20 billion in annual revenues by 2020. -
News Particle Sciences adds sterile powder filling and capsule filling capabilities
Powder fills from 50 mg to 75 g, with an accuracy of up to +/- 1% of fill volume, are now possible, including those for highly potent compounds. -
News New merger between Pfizer and Anacor set to leverage companies in atopic dermatitis space
While Anacor’s crisaborole will benefit from Pfizer in terms of marketing power, its release will subsequently pave the way for Pfizer to launch its own candidate, a topical form of Xeljanz, says GlobalData analyst. -
News Global pharmaceutical firms start prioritising patients over pricing
GSK puts drug affordability before IP protection in low-income countries. -
News Carbogen Amcis expands operations in Bubendorf
The acquired multi-story building is divided into laboratory, production, storage and office areas and provides a set of cleanroom GMP-compliant suites. -
News CMC Biologics expands GMP manufacturing capacity in Europe
Addition of a Bioreactor 3PACK production facility to its Copenhagen facility provides additional flexible solutions for clients. -
News WuXi Biologics and Sartorius Stedim Biotech open joint laboratory in Shanghai
Certified leading upstream platform powers China’s biopharmaceutical development. -
News New data from trials of Opdivo support its efficacy in recurrent metastatic renal cell carcinoma
The drug has been hailed as new standard of care in mRCC due to promising survival outcome rates and objective response rates, say GlobalData analysts. -
News Pharmapack Europe launches new Start-up Hub
All-new addition for 2017 designed to let innovative young pharma firms benefit from valuable networking and learning opportunities -
News Horizon Discovery Group’s molecular reference standards integrated into QIAGEN GeneReader NGS System
Deal demonstrates the impact Horizon's Reference Standards are having in supporting the rapidly growing Next Generation Sequencing (NGS) market. -
News I Holland showcases its new tooling products at Interphex Japan
Tooling products focused on increasing productivity for the tablet manufacturer. -
News Shire shareholders vote to approve combination with Baxalta
Combination would create the global leader in rare diseases. -
News Xellia Pharmaceuticals expands Budapest facilities to strengthen anti-infective product capabilities
Foundation Stone Laying Ceremony of new $10 million Centralized Laboratory Services building attended by Deputy State Secretary Kristóf Altusz from the Hungarian Ministry of Foreign Affairs and Trade, and Mayor Mr Róbert Kovács -
News DCGI gives limited approval to market FIRST Allogeneic cell therapy product in India
Stempeutics puts India on the 'World map of Regenerative Medicine'. -
News Catalent strengthens leadership position in Asia-Pacific
Company announces key appointments and a new sales office in Korea. -
News New research from Accenture reveals gap in Pharma R&D’s journey to delivering better patient outcomes
Adoption of digital transformation to drive patient outcomes may improve competitive position for pharma R&D organizations. -
News Circadian Design now taking pre-orders for Round Refill medication delivery service with smart bottle
Targets $289 billion annual cost to US healthcare system. -
News Colorcon acquires Kollicot Coating Systems line from BASF
Company also advances co-operation to offer superior functional coatings for pharmaceutical tablets. -
News Tablet development made easy
Gemlen tableting launches series of videos discussing the key principles of tableting. -
News Vectura & Propeller Health announce collaboration
The companies will develop digitally-connected inhalers to address chronic respiratory diseases. -
News Double-digit growth for Bosch Packaging Technology
Complete lines and Industry 4.0 solutions are strategic areas of growth. -
News Lilly details robust R&D pipeline to investment community
Company states it has the potential to launch 20 new products in the 10 years beginning in 2014 and extending through 2023. -
News Recipharm unveils serialisation pricing model
New pricing structure will see the removal of any upfront investment costs for pharmaceutical companies looking to access the CDMO’s serialisation capabilities. -
News API manufacturer Olon acquires Infa Group
Acquisition expected to double the Italian manufacturer's generics portfolio. -
News Sanofi announces changes to Executive Committee
Changes aligned to the company's strategic roadmap 2020. -
News Novartis' Entresto given strong Class I recommendation in both US and EU heart failure guidelines
US guidelines now recommend Entresto as standard of care for HFrEF as an alternative to ACEs or ARBs. -
News Recipharm completes acquisition of Kemwell AB and Cirrus Pharmaceuticals Inc.
Acquisitions comprise operations in the US, Sweden and India. -
News Mylan launches first generic Doryx Delayed-Release Tablets, 200 mg
Doxycycline Hyclate DR Tablets are a tetracycline-class antimicrobial indicated as adjunctive therapy for severe acne. -
News Foreign investment and increased imports to dominate Russian and ASEAN markets
Eurasian operations and production strategies examined at CPHI Russia and CPHI South East Asia. -
News BioPharma Services USA awarded a 5 Year, $20 million contract with the FDA
The contract is to conduct in vivo studies of generic drug products in human subjects from 2016 through to 2021. -
News Aptar Pharma provides unit-dose nasal spray technology for the treatment of opioid overdose
The delivery system is for Adept Pharma's Narcan - the first FDA-approved nasally administered, needle-free, ready-to use medication that can stop or reverse the effects of an opioid overdose. -
News Catalent introduces Peel-ID safe storage label to improve storage and retrieval of patient kits
Peel-ID greatly reduces the risk of human error resulting from the incorrect kit being pulled from inventory due to illegible handwriting or incorrectly transposed numbers. -
News Alvotech to acquire Baliopharm
Acquisition provides Alvotech with complimentary capabilities in biosimilar development. -
News Crown Bioscience launches HuScreen — a new high throughput service platform utilizing the largest available collection of PDX models
HuScreen will initially focus on popular indications such as colorectal, gastric, lung (small and non-small cell type), ovarian and breast cancer. -
News ProBioGen to license GlymaxX to Thermo Fisher Scientific for use in developing allergy diagnostics
Afucosylation can enable more precise assessment of allergic sensitization. -
News Catalyst Pharmaceuticals to reduce workforce as part of operating expense management plan
Reduction is part of the company's ongoing efforts to conserve cash as it works to complete the requirements for an NDA submission of Firdapse (amifampridine phosphate) for the treatment of Lambert-Eaton myasthenic syndrome and congenital myasthenic sy... -
News Martindale Pharma expands European commercial activities to include France
Launch of early access programme for Noyada, first novel oral liquid formulation of Captopril targeting paediatric cardiovascular conditions and type 1 diabetic nephropathy. -
News BMS opens expanded biologics facility
$280 million project increases workforce, adds new capabilities -
News Hebei Changshan Biochem Pharma and Albumedix enter into agreement for development of patient-friendly type II diabetes treatment
Albumedix albumin-based half-life extension technology used in clinical development of Hebei Changshan Biochem Pharma’s once-weekly diabetes treatment for the Chinese market. -
News Novartis focuses Pharmaceuticals Division by creating two business units, Novartis Pharmaceuticals and Novartis Oncology
Paul Hudson appointed CEO, Novartis Pharmaceuticals, and Bruno Strigini appointed CEO, Novartis Oncology; David Epstein to leave Novartis. -
News Juniper Pharma Services strengthens topicals capability
The installation and validation of Becomix homogenizer mixer new equipment extends the company’s ability to manufacture creams, ointments, and semi-solids -
News Upcoming PDUFA and ANDA approval dates could catalyse Innovus Pharma and Lipocine
Investors may want to keep a close eye on both of these companies as key FDA response dates approach and PDUFA and ANDA decisions could serve as key catalysts for the stock price. -
News Mylan to acquire Renaissance's leading topicals-focused specialty and generics business
The Business will bring Mylan a complementary portfolio of approximately 25 branded and generic topical products, an active pipeline of approximately 25 products, and an established US sales and marketing infrastructure targeting dermatologists. -
News Veterinary medicine looking increasingly to human drugs to supplement treatment pipelines
Significant unmet needs within veterinary care are driving veterinarians to treat animals such as dogs, cats and horses by prescribing drugs intended for human use. -
News Aptar Pharma's preservative-free multi-dose ophthalmic squeeze dispense launched in the US
First preservative-free multi-dose eye drop featuring Aptar Pharma’s OSD in the US. -
News Disease-modifying drugs to push Huntington’s disease market to $2.6 billion by 2024
The Huntington’s disease pipeline will see exciting new developments over the next decade as disease-modifying drugs transform the market landscape,’ says GlobalData. -
News Collaboration fuels tech expertise in biopharma industry
LZ Lifescience to partner with North Carolina State University’s Biomanufacturing Training and Education Center to help promote and support technology expertise in the biopharma industry. -
News Fujifilm Diosynth Biotechnologies opens new laboratory facility in Research Triangle Park, NC
Construction now complete on new 62,000 square foot facility. -
News Colorcon invests in new film coating manufacturing plant in Brazil
Production of commercial-scale product scheduled for January 2017. -
News Vetter wins the AbbVie TRIUMPH AWARD
Leading CDMO claims prestigious customer award from one of the top-20 biopharmaceutical companies. -
News International pharma specialists meet at Bosch
Representatives of AbbVie, Eli Lilly, NNE Pharmaplan, Roche Diagnostics and Vetter Pharma reported on unusual projects, current challenges and future trends, such as filling of highly potent pharmaceuticals and innovative approaches for the development... -
News Stellar Biotechnologies and Neovacs sign joint venture agreement to manufacture conjugated therapeutic vaccines with Stellar KLH
The purpose of the joint venture is to produce Neovacs' Kinoid immunotherapy product candidates, including IFNa-Kinoid. -
News JHL Biotech opens innovative biosimilars manufacturing facility in China
GE Healthcare delivers world’s first modular manufacturing solution based on single-use bioprocessing technology in just 18 months. -
News Rodolfo Savitzky to succeed Toralf Haag as Lonza Group CFO
Rodolfo Savitzky appointed as new CFO for Lonza Group to succeed Toralf Haag who was appointed as CFO of the Voith Group in Germany -
News CEVEC's CAP-GT sets a new standard through RCA-free production of adenoviral vectors for gene therapy applications
The technology is underway to replace HEK293 as current production host for adenoviral vectors. -
News Expected growth in PBM exclusion lists poses a challenge to drug developers
Tufts CSDD Impact Report says drug developers will be under more pressure to provide harder evidence of clinical superiority and cost-effectiveness of their products -
News Aptuit expands formulation capabilities through acquisition of Kuecept
Expanding capabilities in formulation development to include specialist pre-formulation, formulation prototyping and formulation development services. -
News Pharma tech firms announce global MES partnership
Zenith Technologies and Werum IT Solutions to help improve pharma companies' production performance. -
News Juniper Pharma Services scales up spray-drying capability
Investment in a PSD-1 spray dryer will allow the company to scale-up the process to support later clinical phases and niche commercial scale. -
News Alvogen launches first generic equivalent of Zoladex
Complements a fast growing complex product pipeline in the region. -
News The Rx-360 Upstream Supply Chain Mapping White Paper
The white paper reviews the present state of how the pharmaceutical industry maps its upstream raw material supply chain and the associated challenges that accompany it. -
News Valeant announces patient access and pricing committee to oversee pricing of drugs
Company says it is committed to ensuring previous mistakes are not repeated. -
News MHRA approval of Quay Pharma's GMP manufacturing suites
The new suites are part of a £3 million investment, which has increased the company’s overall manufacturing capacity -
News ICGEB & Sun Pharma sign an exclusive agreement to develop novel botanical drug for treatment of Dengue
Through this agreement, Sun Pharma commits development of Cissampelos pariera (Cipa), a botanical drug in collaboration with ICGEB. -
News Cherwell increases commitment to pharmaceutical microbiology in Republic of Ireland
Ritchie Mooney appointed as Sales Specialist, based in the Republic of Ireland. -
News AMRI to acquire Euticals in a strategic transaction that expands its API development and manufacturing business
Positions AMRI as one of the largest independent developers and suppliers of API to the pharmaceutical industry. -
News Merck builds on leading viral and gene therapy service offering with capacity expansion
Larger Carlsbad, California facility will allow seamless scale-up customer support from clinical to commercial scales. -
News CPHI to launch new North American edition in May 2017
New event will cover full pharmaceutical value chain, bringing together key buyers and sellers of pharmaceutical ingredients, contract services, packaging, machinery/technology, finished dosage formulations and bio services within the North American ma... -
News Chinese companies increase services in finished dosage, exports and bio services at CPHI China 2016
4500 formulations across 60 dosage forms, with 700 APIs and 200 finished products for Western markets present at CPHI China. -
News Brintellix renamed Trintellix in US to avoid name confusion
Name change comes after receiving reports of name confusion in the marketplace between Brintellix and the anti-blood clotting therapy Brilinta (ticagrelor). -
News Biogen announces intent to spin off its hemophilia business
Biogen to focus on novel therapies for neurology. -
News Endo announces US District Court ruling upholding Opana ER intellectual property
The ruling confirms the Court's prior injunction against the manufacture or sale of the generic version of non-crush-resistant Opana ER. -
News Marina Biotech to acquire late-stage program from Turing Pharmaceuticals
Marina to pursue Phase III studies for use of intranasal ketamine in multiple indications. -
News Global dermatology market set to reach $33.7 billion by 2022, despite patent expiries
Strong growth will be driven by a robust late-stage pipeline, including valuable targeted therapies such as dupilumab and ixekizumab, says GBI Research. -
News Graybug Vision announces $44.5 million Series B financing
The proceeds will be used to further the development of GB-102, Graybug Vision’s lead drug for wet AMD, through Phase II clinical trials and to initiate a clinical program for the company’s proprietary glaucoma compound. -
News Merck expands cGMP facility, offering full end-to-end solution for BioPharm customers
Flexible factory concept allows accelerated drug development and delivery to market. -
News Scottish CMO makes US appointment
Senior appointment made just weeks after the sterile manufacturing specialist unveiled a significant surge in demand for its services from the US, driven by biotechnology firms looking for small-scale aseptic manufacturing capabilities in the EU to sup... -
News Allergan receives FDA approval of Crestor
First company to launch a generic version of Crestor to customers in the US. -
News Alnylam breaks ground on new manufacturing facility in Norton, Massachusetts
200,000 sq ft state-of-the-art biopharmaceutical manufacturing facility supports expanding development pipeline and transition toward commercial stage. -
News Merck introduces first multi-use disposable sterile connectors for biopharma
New Lynx CDR connectors facilitate faster and more economic biopharma fluid management. -
News Colorcon delivers savings, speed and flexibility for pharmaceutical film coating with Opadry QX
The system can be applied over a broad range of process conditions, including those containing temperature-sensitive active ingredients. -
News Sanofi offers to acquire Medivation for $52.50 per share in cash
Combination would create complementary offerings to treat prostate cancer. -
News Despite major patent expiries, the hematological cancers market will exceed $70 billion by 2022
Although a number of key patent expiries will occur during the forecast period, new drugs will offset this and drive strong growth, says GBI Research. -
News Pharma Integrates turns five and announces 2016 agenda
The event will be tackling issues such as the rise of precision medicine, disruptive thinking in pharmaceutical regulation, improving patient compliance, future pharmaceutical supply chains and more. -
News Merck launching new single-use products to address biopharma challenges
Launching products at INTERPHEX 2016 include 1000-L bioreactor for greater flexibility and continuity for scale-up. -
News Pall Life Sciences launches commercial Cadence Acoustic Separator for intensified bioprocess clarification and purification applications
The commercial launch of the CAS is the first in a series of product launches that enable continuous bioprocessing. -
News BMS and Merck in race to dominate head and neck cancer market
There is a potential difference of hundreds of millions of dollars in sales at stake across therapy lines between the first-to-market product and the runner-up, says GlobalData -
News Eppendorf Centrifuge 5920 R: the new benchmark in capacity and performance
Also offers a powerful state-of-the-art refrigeration system with advanced temperature management. -
News Catalent wins award at INTERPHEX for its OptiForm Solution Suite platform
OptiForm Solution Suite — designed to efficiently and rapidly help solve complex bioavailability challenges for early-stage molecules, using a unique toolkit of bioavailability enhancing technologies. -
News SGS introduces new bio-layer interferometry analysis for biopharmaceutical development
This new service offers a number of advantages compared with current analytical techniques. -
News Advancing powder compaction analysis with the new Gamlen D series
D-series analysers are supplied with new 'in-die' and 'out-of-die' compaction analysis software that generates tablet detachment and ejection data with full profiles. -
News South Korean pharmaceutical market to grow slowly to $20.4 billion by 2020
The rise will be small due to the government’s focus on reducing healthcare expenditure and the increasing popularity of generics, says GlobalData.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance